Drug Trial Radar · NCT04861259
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
83
Actual
Start
Oct 22, 2021
Primary completion
Oct 9, 2025
Study completion Aug 20, 2029
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- Collaborators
- Chugai Pharmaceutical
- First posted
- Apr 27, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to evaluate the efficacy and safety of crovalimab in adult and adolescent participants with aHUS.
Conditions
- Atypical Hemolytic Uremic Syndrome
Interventions
CrovalimabDrug
Crovalimab will be administered at a dose of 1000 milligrams (mg) intravenous (IV) (for participants with body weight at least 40 (\>=) and up to 100 kilograms (kg) or 1500 mg IV (for participants with body weight \>=100kg) on Week 1 Day 1. On Week 1 Day 2 and on Weeks 2, 3 and 4, it will be administered at a dose of 340 mg subcutaneously (SC). On Week 5 and every 4 weeks (Q4W) thereafter, it will be administered at a dose of 680 mg SC (for participants with body weight \>= 40kg to \<100kg) or 1020 mg SC (for participants with body weight \>=100kg).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Naive Cohort: Percentage of Participants With Complete Thrombotic Microangiopathy Response (cTMAr) Anytime From Baseline to Week 25Time frame: Baseline up to Week 25 (after 24 weeks on treatment)
Locations
41 sites in 16 countries. Site status is shown where the registry gives one.
Univ of CA San Francisco
San Francisco, California
Children's Hospital Colorado
Aurora, Colorado
Emory Children's Center
Atlanta, Georgia
Washington University
St Louis, Missouri
The Ohio State University Wexner Medical Center
Columbus, Ohio
UT Health Science Center
San Antonio, Texas
UZ Leuven Gasthuisberg
Leuven, Belgium
Santa Casa de Misericordia
Belo Horizonte, Minas Gerais, Brazil
UPECLIN Hospital das Clinicas da Faculdade de Medicina de Botucatu
Botucatu, São Paulo, Brazil
Hospital das Clinicas - FMUSP
São Paulo, São Paulo, Brazil
Vancouver General Hospital
Vancouver, British Columbia, Canada
Peking University First Hospital
Beijing, China
Hopital Lapeyronie
Montpellier, France
Hôpital Robert Debré
Paris, France
Hopital Tenon
Paris, France
Klinik II für Nephrologie, Rheumatologie, Diabetologie und Allgemeine Innere Medizin
Cologne, Germany
Universitätsklinikum Essen
Essen, Germany
Klinik für Nephrologie des Universitätsklinikum Essen
Essen, Germany
Medizinische Hochschule Hannover
Hanover, Germany
Del- Pesti Centrumkorhaz- Szent Laszlo Korhaz Telephely
Budapest, Hungary
All India Institute Of Medical Sciences (AIIMS)
New Delhi, National Capital Territory of Delhi, India
Rambam Medical Center
Haifa, Israel
Rabin Medical Center
Petah Tikva, Israel
Sheba MC
Ramat Gan, Israel
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, Lazio, Italy
A.O. Universitaria S. Martino Di Genova
Genoa, Liguria, Italy
Nagoya University Hospital
Aichi, Japan
Saitama Medical University Hospital
Saitama, Japan
The University of Tokyo Hospital
Tokyo, Japan
Hospital de Especialidades Puerta de Hierro S.A de C.V.
Zapopan, Mexico
Hospital General de México
Distrito Federal, Mexico CITY (federal District), Mexico
Instituto Nacional de Ciencias
Mexico City, Mexico CITY (federal District), Mexico
Hospital Universitario "Dr. Jose Eleuterio Gonzalez"
Monterrey, Nuevo León, Mexico
Instytut ?Centrum Zdrowia Matki Polki
Lodz, Poland
Complejo Hospitalario Universitario A Coruña (CHUAC)
A Coruña, Spain
Hospital Clinic i Provincial
Barcelona, Spain
Hospital Universitario Virgen del Rocío
Seville, Spain
Istanbul University Istanbul Medical Faculty
Istanbul, Turkey (Türkiye)
Kocaeli University Medical Faculty
Kocaeli, Turkey (Türkiye)
Necmettin Erbakan University Meram Medical Faculty
Konya, Turkey (Türkiye)
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.